TETRALOGIC PHARMACEUTICALS CORP (TLOG) has 31 open-market insider trades by 15 insiders since 2013. The most active filer is J. Kevin Buchi, President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Robert Liptak | 10% Owner | — | 2 | $10.1M | 2016-01-28 |
| Healthcare Ventures VII L.P. | 10% | — | 1 | $5.0M | 2013-12-17 |
| Paul J. Schmitt | Dir | — | 3 | $3.2M | 2015-07-02 |
| J. Kevin Buchi | Pres | — | 7 | $2.2M | 2015-03-26 |
| Ventures Llc Amgen | 10% | — | 1 | $1.9M | 2013-12-17 |
| James N. Woody | Dir | — | 1 | $1.8M | 2013-12-17 |
| Peter A. Meyers | Treasurer | — | 2 | $1.0M | 2014-11-12 |
| Douglas Reed M.D. | Dir | — | 1 | $1000K | 2013-12-17 |
| Andrew L. Pecora | Dir | — | 4 | $531K | 2015-07-10 |
| Clarus Ventures II, LLC | 10% Owner | — | 1 | $486K | 2016-02-05 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Ventures Ii Gp L.p. Clarus | 10% | Sell | $56K | 2016-02-08 |
| Clarus Ventures II, LLC | 10% Owner | Sell | $486K | 2016-02-03 |
| Nicholas Simon | 10% | Sell | $72K | 2016-01-29 |
| Robert Liptak | 10% Owner | Sell | $143K | 2016-01-26 |
| Andrew L. Pecora | Director | Buy | $134K | 2015-07-10 |
| Andrew L. Pecora | Director | Buy | $120K | 2015-07-09 |
Companies that share insiders with TLOG, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Paul J. Schmitt | Director | Buy | $23K | 2015-07-02 |
| J. Kevin Buchi | President | Buy | $21K | 2015-03-26 |
| J. Kevin Buchi | President | Buy | $25K | 2015-01-07 |
| Colin Glenn Begley | Chief Scientific Officer & SVP | Buy | $37K | 2014-12-10 |
| Colin Glenn Begley | Chief Scientific Officer & SVP | Buy | $36K | 2014-12-10 |
| J. Kevin Buchi | President | Buy | $30K | 2014-12-09 |
| Pete A. Meyers | Treasurer | Buy | $5K | 2014-12-04 |
| J. Kevin Buchi | President | Buy | $50K | 2014-12-02 |
| Lesley Russell | COO | Buy | $98K | 2014-11-26 |